CompaniesOncomatryx Biopharma
Oncomatryx Biopharma logo

Oncomatryx Biopharma

active
Derio, Spain
Founded 2009
Website
About

Antibody-Drug Conjugates

Areas of Focus

Categories

Biologics & BiopharmaceuticalAntibody
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

120

By Phase

PHASE1: 1

By Status

RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
Today
NCT05547321
Hover over trial bars to see details

Recent Trials

NCT05547321Lead Sponsor
Efficacy and Safety Study of OMTX705, Monotherapy and Pembrolizumab-combined, in Subjects With Advanced Solid Tumors.
PHASE1Recruiting
120 participants
Started: Oct 20, 2022 · Completed: Oct 31, 2024
Locations (1)
Headquarters
Derio, Spain
Map

Loading map...